findmyKOL

Anusha Vakiti

Basic profile

Hematology / Oncology

ORCIDNPI
RegionWashington, DC · NortheastSpecialtyHematology / OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Anusha Vakiti is an Oncology physician. OpenAlex indexes 33 publications with 1,726 citations (h-index 10).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
33publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,726citations

Total citations across indexed works.

10h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
63companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

110 Irving St NW
Dept Of Internal Medicine
Washington, DC 200103017

Telephone

202-877-2835

Provider last certified this registry record 25 May 2022.

View the NPPES registry record

Industry payments

63 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    34.3%
    Aromatase Inhibitor12.8%
    Anastrozole66%Letrozole28%Exemestane6%
    Part D<11 patients
    Thalidomide Analog10.9%
    Revlimid51%Pomalyst34%Lenalidomide15%
    Part D<11 patients

    + 5 more classes in this area

  • Nervous system

    27.3%
    Opioid Agonist16.1%
    Oxycodone Hcl50%Tramadol Hcl15%Oxycodone-Acetaminophen13%Morphine Sulfate Er11%Oxycontin7%Fentanyl4%
    Part D<11 patients
    Gabapentinoids4.8%
    Gabapentin71%Pregabalin29%
    Part D<11 patients

    + 5 more classes in this area

  • Metabolism & gastrointestinal

    14.5%
    Serotonin-3 Receptor Antagonist4.6%
    Ondansetron Hcl68%Ondansetron Odt32%
    Part D45 patients
    Proton pump inhibitor3.8%
    Pantoprazole Sodium100%
    Part D18 patients

    + 4 more classes in this area

Where care is delivered (Part B)42.4% facility · 57.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”